GLP Expansion Kronos Science Laboratory is expanding from standard contract research to GLP and GLP-like services, signaling opportunities to target regulated pharmaceutical and clinical trial clients who require compliance-ready testing and documentation.

SME Focus With a small team (2-10 employees) and niche offerings in oxidative stress, fatty acid, vitamin, nutrition, and hormone panels, there is a clear opportunity to upsell through strategic partnerships and white-label CRO engagements with larger pharma networks.

Diverse Client Access KS services both directly to pharma/biotech firms and as a subcontractor to central labs and clinical trial sites, indicating multiple entry points for outreach and co-selling with larger CRO ecosystems.

Financial Positioning Estimated revenue of 10–25 million places Kronos in a mid-market tier where targeted storytelling around quality, compliance, and speed can unlock mid-to-large project wins from comparable peers and larger institutes.

Tech & Trust Leverage their GLP capability, along with strong cloud and web tech (AWS, Google Cloud, React), to emphasize secure data handling, scalable analysis, and modern collaboration tools as differentiators when approaching risk-averse pharmaceutical clients.